Inventor · San Jose, CA, US

Bing Wang

54Patents
12h-index
101Co-inventors
87Inventor score

Filing activity: Mar 9, 2001 → May 25, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US6608196B2 Process for solid supported synthesis of pyruvate-derived compounds Human Necessities 74 Expired
US6653346B1 Cytoprotective benzofuran derivatives Chemistry; Metallurgy 56 Expired
US7470798B2 7,8-bicycloalkyl-chroman derivatives Chemistry; Metallurgy 49 Expired
US7514461B2 Chroman derivatives Chemistry; Metallurgy 46 Expired
US7034054B2 Methods for the prevention and treatment of cerebral ischemia using non-alpha tocopherols Human Necessities 44 Expired
US7078541B2 Benzofuran derivatives Chemistry; Metallurgy 36 Expired
US7875607B2 7,8-bicycloakyl-chroman derivatives Chemistry; Metallurgy 34 Active
US8044097B2 Chroman derivatives Chemistry; Metallurgy 33 Active
US8012976B2 Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) Human Necessities 32 Active
US6900218B2 Pyruvate derivatives Human Necessities 26 Expired
US8088760B2 Benzoxazole carboxamide inhibitors of poly(ADP-ribose)polymerase (PARP) Chemistry; Metallurgy 23 Active
US8791155B2 Chroman derivatives Chemistry; Metallurgy 19 Active
US8735392B2 Crystalline (8S,9R)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one tosylate salt Human Necessities 12 Active
US8541403B2 Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in treatment of diseases associated with a PTEN deficiency Human Necessities 12 Active
US8420650B2 Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) Human Necessities 11 Active
US9139580B2 Glucosylceramide synthase inhibitors Chemistry; Metallurgy 10 Active
US8999987B2 Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) Human Necessities 8 Active
US8765945B2 Processes of synthesizing dihydropyridophthalazinone derivatives Chemistry; Metallurgy 8 Active
US8703761B2 Organic compounds Chemistry; Metallurgy 7 Active
US7629375B2 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods Chemistry; Metallurgy 7 Active
US9018201B2 Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in treatment of diseases associated with a PTEN deficiency Human Necessities 7 Active
US7035550B2 All-optical, 3R regeneration using the Sagnac and Mach-Zehnder versions of the terahertz optical asymmetric demultiplexer (TOAD) Electricity 6 Expired
US9820985B2 Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) Human Necessities 6 Active
US9926303B2 Processes of synthesizing dihydropyridophthalazinone derivatives Chemistry; Metallurgy 5 Active
US8680114B2 AKT protein kinase inhibitors Emerging Cross-Sectional Technologies 5 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.